中文 | English
Return
Total: 42 , 1/5
Show Home Prev Next End page: GO
MeSH:(Immunologic Factors/pharmacology)

1.Action mechanism of lenalidomide in hematological malignancies - review.

Li-Rong LIU ; Shen-Xian QIAN

Journal of Experimental Hematology 2012;20(4):1039-1041

2.Advance in studies on anti-inflammatory and immunoregulatory monomers of Tripterygium wilfordii.

Chun-Xing LI ; Tai-sheng LI ; Zhu ZHU ; Jing XIE ; Lv WEI

China Journal of Chinese Materia Medica 2014;39(21):4159-4164

4.Advance in studies on mechanism of active anti-tumor compounds from sponge.

Feng YANG ; Hong YUAN ; Zhi-jun HUANG

China Journal of Chinese Materia Medica 2012;37(19):2842-2845

5.Research Advances of Immunotherapy for Follicular Lymphoma --Review.

Li-Hua QIU ; Ya-Xin ZHENG ; Zhi-Rong ZHENG ; Chen TIAN

Journal of Experimental Hematology 2022;30(2):627-630

6.Research progress of pharmacological activities and analytical methods for plant origin proteins.

Chun-hong LI ; Cen CHEN ; Zhi-ning XIA ; Feng-qing YANG

China Journal of Chinese Materia Medica 2015;40(13):2508-2517

7.Flavonoids Modulate the Proliferation of Neospora caninum in Glial Cell Primary Cultures.

Rosan BARBOSA DE MATOS ; Suzana BRAGA-DE-SOUZA ; Bruno PENA SEARA PITANGA ; Victor Diogenes AMARAL DA SILVA ; Erica Etelvina VIANA DE JESUS ; Alexandre MORALES PINHEIRO ; Maria de Fatima DIAS COSTA ; Ramon DOS SANTOS EL-BACHA ; Catia Suse DE OLIVEIRA RIBEIRO ; Silvia LIMA COSTA

The Korean Journal of Parasitology 2014;52(6):613-619

8.Evaluation of immune regulation effects of Chinese medicinal formulae based on immunomics of traditional Chinese medicine.

Hui LIU ; Yue-Qiu GUO

China Journal of Chinese Materia Medica 2008;33(24):2958-2960

9.Changes of serum interferon-gamma levels in mice bearing S-180 tumor and the interventional effect of immunomodulators.

Li LI ; Lin-Sheng LEI ; Chuan-Lin YU

Journal of Southern Medical University 2008;28(1):65-68

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 42 , 1/5 Show Home Prev Next End page: GO